Tech Company Financing Transactions

Visus Therapeutics Funding Round

Visus Therapeutics, operating out of Seattle, scored $36 million from Johnson & Johnson Development Corporation, RTW Investments and private investors.

Transaction Overview

Company Name
Announced On
3/10/2021
Transaction Type
Venture Equity
Amount
$36,000,000
Round
Series A
Proceeds Purpose
The company intends to use the funds to advance the clinical development program for its lead asset, BRIMOCHOL.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2 Nickerson St. 101
Seattle, WA 98109
USA
Email Address
Not Recorded
Overview
Visus Therapeutics is a clinical-stage company developing innovative medicines to improve vision for people around the world. Visus Therapeutics has assembled a team of renowned leaders with vast eye care experience, united by the common goal of advancing drug discovery to benefit the patients we serve.
Profile
Visus Therapeutics LinkedIn Company Profile
Social Media
Visus Therapeutics Company Twitter Account
Company News
Visus Therapeutics News
Facebook
Visus Therapeutics on Facebook
YouTube
Visus Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Benjamin Bergo
  Benjamin Bergo LinkedIn Profile  Benjamin Bergo Twitter Account  Benjamin Bergo News  Benjamin Bergo on Facebook
Chief Financial Officer
David Toll
  David Toll LinkedIn Profile  David Toll Twitter Account  David Toll News  David Toll on Facebook
Chief Medical Officer
Rhett Schiffman
  Rhett Schiffman LinkedIn Profile  Rhett Schiffman Twitter Account  Rhett Schiffman News  Rhett Schiffman on Facebook
Chief Operating Officer
Timothy Grinstead
  Timothy Grinstead LinkedIn Profile  Timothy Grinstead Twitter Account  Timothy Grinstead News  Timothy Grinstead on Facebook
Controller
Lee Merrill
  Lee Merrill LinkedIn Profile  Lee Merrill Twitter Account  Lee Merrill News  Lee Merrill on Facebook
Vice President
Patrick Hughes
  Patrick Hughes LinkedIn Profile  Patrick Hughes Twitter Account  Patrick Hughes News  Patrick Hughes on Facebook
Vice President
Alex Oh
  Alex Oh LinkedIn Profile  Alex Oh Twitter Account  Alex Oh News  Alex Oh on Facebook
VP - Human Resources
Esther Cuno
  Esther Cuno LinkedIn Profile  Esther Cuno Twitter Account  Esther Cuno News  Esther Cuno on Facebook
VP - Marketing
Carey Powers
  Carey Powers LinkedIn Profile  Carey Powers Twitter Account  Carey Powers News  Carey Powers on Facebook
VP - Operations
Cam Dang
  Cam Dang LinkedIn Profile  Cam Dang Twitter Account  Cam Dang News  Cam Dang on Facebook
VP - Operations
Lisa Simpson
  Lisa Simpson LinkedIn Profile  Lisa Simpson Twitter Account  Lisa Simpson News  Lisa Simpson on Facebook
VP - Operations
Zohra Womack
  Zohra Womack LinkedIn Profile  Zohra Womack Twitter Account  Zohra Womack News  Zohra Womack on Facebook
VP - R & D
James Burke
  James Burke LinkedIn Profile  James Burke Twitter Account  James Burke News  James Burke on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/10/2021: ActZero venture capital transaction
Next: 3/10/2021: Cube venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document funding rounds that are announced publicly. VC investment data records reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary